Multimerization of peptide antigens for production of stable immunogens in transgenic plants

Journal of Biotechnology

Volumn 128, Issue 3, 2007, Pages 512-518

  Gil, Félix ^a   Reytor, Edel ^a   Pérez Filgueira, Daniel Mariano ^a,b   Escribano, José M ^a  

^a INIA   (Spain)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Multimerization; Peptide; Recombinant vaccines; Transgenic plants

Indexed keywords

CELL CULTURE; DNA; IMMUNOLOGY; MONOMERS; PROTEINS;

IMMUNOGENICITY; MULTIMERIZATION; RECOMBINANT VACCINES; TRANSGENIC PLANTS;

ANTIGENS;

BETA GLUCURONIDASE; CHIMERIC PROTEIN; PROTEIN P53; PROTEIN VP2;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARABIDOPSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENETICS; MOLECULAR CLONING; MOUSE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSGENIC PLANT;

AMINO ACID SEQUENCE; ANIMALS; ARABIDOPSIS; CAPSID PROTEINS; IMMUNIZATION; MICE; MOLECULAR SEQUENCE DATA; PARVOVIRUS, CANINE; PEPTIDE FRAGMENTS; PLANTS, GENETICALLY MODIFIED; POLYMERS; RECOMBINANT FUSION PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; VACCINES, SYNTHETIC;

ARABIDOPSIS THALIANA; CANINE PARVOVIRUS; MUS;

EID: 33846339774     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2006.11.001     Document Type: Article

References (36)

1. Canizares M.C., Nicholson L., and Lomonossoff G.P. Use of viral vectors for vaccine production in plants. Immunol. Cell Biol. 83 (2005) 263-270
2. Casal J.I., Langeveld J.P., Cortes E., Schaaper W.W., van Dijk E., Vela C., Kamstrup S., and Meloen R.H. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J. Virol. 69 (1995) 7274-7277
3. Conrad U., and Fiedler U. Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol. Biol. 38 (1998) 101-109
4. Dus Santos M.J., Wigdorovitz A., Trono K., Ríos R.D., Franzone P.M., Gil F., Moreno J., Carrillo C., Escribano J.M., and Borca M.V. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine 20 (2002) 1141-1147
5. Fernández-Carneado J., Kogan M.J., Castel S., and Giralt E. Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein. Angew. Chem. Int. Ed. Engl. 43 (2004) 1811-1814
6. Fischer R., Stoger E., Schillberg S., Christou P., and Twyman R.M. Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol. 7 (2004) 152-158
7. George Chandy A., Hultkrantz S., Raghavan S., Czerkinsky C., Lebens M., Telemo E., and Holmgren J. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells. Immunology 118 (2006) 311-320
8. Giddings G. Transgenic plants as protein factories. Curr. Opin. Biotechnol. 12 (2001) 450-454
9. Gil F., Brun A., Wigdorovitz A., Catala R., Martinez-Torrecuadrada J.L., Casal I., Salinas J., Borca M.V., and Escribano J.M. High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Lett. 488 (2001) 13-17
10. Gil F., Titarenko E., Terrada E., Arcalís E., and Escribano J.M. Successful oral prime-immunization with VP60 from rabbit haemorrhagic disease virus produced in transgenic plants using different fusion strategies. Plant Biotechnol. J. 4 (2006) 135-143
11. Gomez N., Carrillo C., Salinas J., Parra F., Borca M.V., and Escribano J.M. Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants. Virology 249 (1998) 352-358
12. Jeffrey P.D., Gorina S., and Pavletich N.P. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267 (1995) 1498-1502
13. Krebbers E., and Vandekerckhove J. Production of peptides in plant seeds. Trends Biotechnol. 8 (1990) 1-3
14. Kogan M.J., Dalcol I., Gorostiza P., Lopez-Iglesias C., Pons M., Sanz F., Ludevid D., and Giralt E. Self-assembly of the amphipathic helix (VHLPPP)8. A mechanism for zein protein body formation. J. Mol. Biol. 312 (2001) 907-913
15. Langeveld J.P., Casal J.I., Osterhaus A.D., Cortes E., de Swart R., Vela C., Dalsgaard K., Puijk W.C., Schaaper W.M., and Meloen R.H. First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J. Virol. 68 (1994) 4506-4513
16. Lopez de Turiso J.A., Cortes E., Martinez C., Ruiz de Ybanez R., Simarro I., Vela C., and Casal I. Recombinant vaccine for canine parvovirus in dogs. J. Virol. 66 (1992) 2748-2753
17. Ma J.K., Drake P.M., and Christou P. The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Genet. 4 (2003) 794-805
18. Mason H.S., Ball J.M., Shi J.J., Jiang X., Estes M.K., and Arntzen C.J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5335-5340
19. Molina A., Hervas-Stubbs S., Daniell H., Mingo-Castel A., and Veramendi J. High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. J. 2 (2004) 141-153
20. Molina A., Veramendi J., and Hervas-Stubbs S. Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus. Virology 342 (2005) 266-275
21. Pérez-Filgueira M., Wigdorovitz A., Romera A., Zamorano P., Borca M.V., and Sadir A.M. Detection and characterization of functional T-cell epitopes on the structural proteins VP2, VP3, and VP4 of foot and mouth disease virus O1 Campos. Virology 271 (2000) 234-239
22. Pérez-Filgueira D.M., Brayfield B.P., Phiri S., Borca M.V., Wood C., and Morris T.J. Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector. J. Virol. Methods 121 (2004) 201-208
23. Renjifo X., Wolf S., Pastoret P.P., Bazin H., Urbain J., Leo O., and Moser M. Carrier-induced, hapten-specific suppression: a problem of antigen presentation?. J. Immunol. 161 (1998) 702-706
24. Rheinnecker M., Hardt C., Ilag L.L., Kufer P., Gruber R., Hoess A., Lupas A., Rottenberger C., Pluckthun A., and Pack P. Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen. J. Immunol. 157 (1996) 2989-2997
25. Richter L.J., Thanavala Y., Arntzen C.J., and Mason H.S. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18 (2000) 1167-1171
26. Sakamoto H., Lewis M.S., Kodama H., Appella E., and Sakaguchi K. Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8974-8978
27. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. second ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
28. Schagger H., and von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166 (1987) 368-379
29. Sciutto E., Fragoso G., Manoutcharian K., Gevorkian G., Rosas-Salgado G., Hernández-González M., Herrera-Estrella L., Cabrera-Ponce J., López-Casillas F., González-Bonilla C., Santiago-Machuca A., Ruiz-Pérez F., Sánchez J., Goldbaum F., Aluja A., and Larralde C. New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis. Arch. Med. Res. 33 (2002) 371-378
30. Skosyrev V.S., Rudenko N.V., Yakhnin A.V., Zagranichny V.E., Popova L.I., Zakharov M.V., Gorokhovatsky A.Y., and Vinokurov L.M. EGFP as a fusion partner for the expression and organic extraction of small polypeptides. Protein Expr. Purif. 27 (2003) 55-62
31. Streatfield S.J., Lane J.R., Brooks C.A., Barker D.K., Poage M.L., Mayor J.M., Lamphear B.J., Drees C.F., Jilka J.M., Hood E.E., and Howard J.A. Corn as a production system for human and animal vaccines. Vaccine 21 (2003) 812-815
32. Tacket C.O. Plant-derived vaccines against diarrheal diseases. Vaccine 23 (2005) 1866-1869
33. Varsani A., Williamson A.L., Stewart D., and Rybicki E.P. Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. Virus Res. 120 (2006) 91-96
34. Walker D.R., Bond J.P., Tarone R.E., Harris C.C., Makalowski W., Boguski M.S., and Greenblatt M.S. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene 18 (1999) 211-218
35. Wigdorovitz A., Mozgovoj M., Santos M.J., Parreño V., Gomez C., Pérez-Filgueira D.M., Trono K.G., Rios R.D., Franzone P.M., Fernandez F., Carrillo C., Babiuk L.A., Escribano J.M., and Borca M.V. Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants. J. Gen. Virol. 85 (2004) 1825-1832
36. Willuda J., Kubetzko S., Waibel R., Schubiger P.A., Zangemeister-Wittke U., and Pluckthun A. Tumor targeting of mono-, di-, and tetravalent anti-p185(HER-2) miniantibodies multimerized by self-associating peptides. J Biol Chem. 276 (2001) 14385-14392